Earnings transcript
Niva Bupa Q4/FY26 Earnings Call Transcript
Transcript: Niva Bupa Q4/FY26 earnings call reporting FY26 GWP ₹9,433cr (+27.4%), PAT ₹366cr (+80%), retail growth 35%, ROE 10.7%, combined ratio 101.4% and expense ratio down to 33.7%.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Niva Bupa Health Insurance Company Ltd (NIVABUPA) is currently trading at 81.49 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Niva Bupa Health Insurance Company Limited is a standalone health insurer focusing on the retail health market. It underwrites health insurance, personal accident, critical illness, and travel insurance products in India. The company is a joint venture between Bupa Singapore Holdings and Fettle Tone LLP. In 9M'FY2026, Niva Bupa reported a Gross Written Premium (GWP) of ₹6,309 crore, up 25.9% year-on-year. Profit after tax for the same period stood at ₹208 crore, reflecting a robust growth of 74.3% over the previous year. Niva Bupa's digital transformation and multi-channel distribution approach have significantly expanded business reach, with digital channels showing an impressive growth of 49% for the nine months. Their Retail Health market share increased to 10.0%. The introduction of Niva Bupa's ReAssure 3.0 product, designed to combat high medical inflation, has been successful since its launch. It offers unlimited sum insured and comprehensive OPD services, enhancing customer attraction and retention. The company maintains a strong focus on technological advancements, evidenced by its AI-driven claims management and customer engagement processes. These initiatives aim to enhance efficiency and customer satisfaction.
Over the past 52 weeks, Niva Bupa Health Insurance Company Ltd has traded between a low of ₹61.01 and a high of ₹95.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Niva Bupa Health Insurance Company Ltd has a market capitalization of approximately 14,977.33. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Niva Bupa Health Insurance Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 114.52 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 14,977.33 Cr, Niva Bupa Health Insurance Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Niva Bupa Health Insurance Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Niva Bupa Health Insurance Company Ltd is 114.52. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Net earned premium grew 28% to INR 4,894 crore in FY25.
The stock rose after the company reported Q4FY26 net profit of ₹345.13 crore, up 67.4% year-on-year, alongside higher premium earned and improved operating margin.
The stock moved up after Niva Bupa reported a 67.4% year-on-year jump in Q4FY26 net profit to ₹345.13 crore and higher premium earned and total income.
Niva Bupa reported net profit of ₹345 crore for the March quarter, up 67% from ₹206 crore in the year-ago period.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Insurance
General Insurance
15,055 Cr
Low Risk
115.1
15.9
1.3
4.0
95.00
61.01
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
6
Bullish
5
Bearish
4
Neutral
7
Bullish
35
Bearish
1
Neutral
1
Bullish
30
Earnings transcript
Transcript: Niva Bupa Q4/FY26 earnings call reporting FY26 GWP ₹9,433cr (+27.4%), PAT ₹366cr (+80%), retail growth 35%, ROE 10.7%, combined ratio 101.4% and expense ratio down to 33.7%.
Earnings Call
Transcript of Niva Bupa’s Q4 & FY26 earnings call: GWP INR9,433 crore (+27.4% YoY), retail +35%, PAT INR366 crore (up ~80% YoY), ROE 10.7%, combined ratio 101.4%, expense ratio improved to 33.7%; IFRS17 adoption and operational/tech initiatives noted.